Neuronetics (STIM)
(Delayed Data from NSDQ)
$0.91 USD
+0.05 (5.81%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $0.91 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.91 USD
+0.05 (5.81%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $0.91 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Zacks News
Neuronetics (STIM) Looks Good: Stock Adds 11.3% in Session
by Zacks Equity Research
Neuronetics (STIM) saw a big move last session, as its shares jumped more than 11% on the day, amid huge volumes.
Neuronetics (STIM) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Neuronetics (STIM) delivered earnings and revenue surprises of -54.55% and -3.56%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Snap Up These 5 Stocks With Rising P/E
by Sanghamitra Saha
Bet on these top--ranked stocks with rising P/E to realize outsized gains.
Neuronetics (STIM) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Neuronetics (STIM) delivered earnings and revenue surprises of 8.89% and 2.09%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Neuronetics (STIM) Q4 Earnings Expected to Decline
by Zacks Equity Research
Neuronetics (STIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Neuronetics (STIM) delivered earnings and revenue surprises of 9.76% and -0.78%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Neuronetics (STIM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Neuronetics (STIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Neuronetics (STIM) delivered earnings and revenue surprises of 9.30% and 4.89%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?